Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-5 WOUNDS B-Treatment of wounds and injuries contaminated by B agents
Projektleitung: Kircher Julia
Laufzeit: 01.11.2025 - 31.10.2028
Geldgeber: Europäische Kommission

Second research action for medical counter measures against CBRN threats performed in the frame of the RESILIENCE FPA consortium: SP-4 BIOMARKERS B-New biomarkers of infection by B threat agents
Projektleitung: Kircher Julia
Laufzeit: 01.11.2025 - 31.10.2028
Geldgeber: Europäische Kommission

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):

01.12.2025:

Shraim, R; Timofeeva, M; Wyse, C; van, Geffen, J; van, Weele, M; Romero-Ortuno, R; Lopez, LM; Kleber, ME; Pilz, S; März, W; Fletcher, BS; Wilson, JF; Theodoratou, E; Dunlop, MG; McManus, R; Zgaga, L Genome-wide gene-environment interaction study uncovers 162 vitamin D status variants using a precise ambient UVB measure.
Nat Commun. 2025; 16(1): 10774 Doi: 10.1038/s41467-025-65820-x [OPEN ACCESS]
PubMed FullText FullText_MUG

 

01.12.2025:

Höckendorf, U; Dutta, S; Kloos, A; Runtsch, M; Zötsch, C; Vosberg, S; Wang, Y; Kienreich, S; Flasch, B; Malovan, G; Jäger, V; Stanzer, S; Prein, S; Odinius, TO; Wagner, CV; Buschhorn, L; Dill, V; Perfler, B; Haferlach, T; Döhner, K; Götze, KS; Ruland, J; Bassermann, F; Wahida, A; Heikenwälder, M; Branca, C; Schmöllerl, J; Zuber, J; Burk, AC; Zeiser, R; Sill, H; Jayavelu, AK; Zebisch, A; Heuser, M; Dengler, MA; Jost, PJ Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.
Sci Transl Med. 2025; 17(826): eadu3313 Doi: 10.1126/scitranslmed.adu3313
PubMed FullText FullText_MUG

 

01.12.2025:

Jeys, L; Botello, E; Boyle, RA; Ebeid, W; Houdek, MT; Kurisunkal, VJ; Morgan-Jones, R; Morris, GV; Puri, A; Ruggieri, P; Laitinen, MK; Abad, Repiso, S; Abdelbary, H; Abiad, Mejia, A; Abood, AA; Abou-Nouar, G; Abril, Martin, JC; Abu, Elhamd, A; Abudu, A; Acosta, M; Ae, K; Agarwal, M; Ajit, Singh, V; Akiyama, T; Albergo, JI; Alexander, J; Alfaro, PA; Alpan, B; Alshaygy, I; Amaya-Valero, J; Anderson, M; Andreou, D; Annabell, L; Anthony, C; Aoude, A; Arteagoitia-Colino, I; Asavamongkolkul, A; Aston, W; Asua, Mentxaka, L; Azzopardi, C; Baad-Hansen, T; Badr, IT; Baixauli-Garcia, F; Baker, G; Balach, T; Baldi, GG; Barry, J; Basile, G; Bastoni, S; Basuki, MH; Bauer, H; Bayliss, L; Becker, RG; Bedi, A; Benevenia, J; Bengoa, F; Bergh, P; Bergovec, M; Bernthal, N; Binitie, O; Boddie, D; Boffano, M; Bonilla, Huertas, P; Borgognoni, AB; Botchu, R; Bramer, J; Branford-White, H; Brar, R; Broekhuis, D; Broida, SE; Budny, T; Burke, ZD; Cabrolier, J; Calvo, Tapies, JR; Calvo-Haro, JA; Campanacci, D; Cardoso, R; Carey, Smith, R; Carvallo, PI; Casales, Fresenga, N; Casanova, JM; Ceballos, O; Cebrian, Parra, JL; Certain, LK; Chacon, Cartaya, S; Chan, CM; Cho, YJ; Choong, P; Chung, YG; Ciechanowicz, D; Clara-Altamirano, MA; Clever, D; Colina, SM; Consuegra, L; Couch, C; Cribb, G; Cuervo, C; Cusick, LA; Dadia, S; Dagher, T; Dammerer, D; Davies, M; Davies, N; de, la, Rosa, Martino, LP; de, Santos, de, la, Fuente, FJ; de, Vaal, M; Deckers, C; Delgado, Obando, J; Deo, S; Deventer, N; Di, Bella, C; Domson, G; Donati, DM; Dorleijn, DM; Du, Toit, J; Dunne, D; Duran, Ciarrochi, R; Ekman, E; El, Ghoneimy, AM; Endo, M; Eralp, L; Etaiwi, M; Evans, S; Evrard, R; Eward, W; Farese, A; Ferguson, PC; Ferreira, Cardoso, PF; Fiorenza, F; Flint, M; Flores, H; Freitas, J; Fuchs, B; Fujiwara, T; Funovics, PT; Galli, Serra, M; Gamie, Z; Garces-Zarzalejo, C; Gazendam, A; Gebert, C; Gerbers, JG; Gerrand, C; Ghert, M; Ghosh, KM; Gibbons, M; Gomez-Mascard, A; Gomez-Mier, LC; Gomez-Vallejo, J; Gonzalez, MR; Gonzalez-Lizan, F; Gosheger, G; Goudie, S; Goulding, K; Goumenos, SD; Griffin, A; Gulia, A; Gupta, S; Gupta, A; Guzman, M; Haitham, M; Hardes, J; Hardoy, F; Hasan, Y; Hauer, G; Havard, H; Haydon, R; Healey, J; Hernandez, Gonzalez, N; Hernandez-Lopez, A; Hesla, A; Hess, M; Hilton, T; Hongsaprabhas, C; Hornicek, F; Hosking, K; Houghton, E; Idowu, OK; Ippolito, J; Isler, M; Iwata, S; Jagiello, J; Jenkins, N; Jeys, T; Jeys, C; Johnson, L; Johnston, A; Joo, MW; Jutte, PC; Kaldas, K; Kamat, A; Kannan, S; Kapanci, B; Khan, Z; Kobayashi, H; Kollender, Y; Koob, S; Kotrych, D; Kyte, R; Lamo, de, Espinosa, Vazquez, de, Sola, JM; Lazarides, AL; Le, Nail, LR; Legosz, P; Lehner, B; Leithner, A; Lejoly, M; Lewis, VO; Lin, P; Linares, F; Lozano-Calderon, S; Mahendra, A; Mahyudin, F; Mandia, Mancebo, FJ; Martos, Torrejon, S; Marx, C; Mascard, E; Mattei, JC; McCullough, L; McMahon, S; Medellin, Rincon, MR; Miller, B; Miwa, S; Molina, Uribe, G; Moon, B; Moriel, Garcesco, DJ; Morris, C; Morrison, S; Mottard, S; Moura, M; Muster, L; Nakayama, R; Narhari, P; Navas, A; Nayak, P; Neugebauer, J; Newman, ET; Nieminen, J; Nyqvist, E; Nystrom, L; O'Reilly-Harbidge, S; O'Toole, G; Oliveira, V; Olivier, A; Omar, M; Ortiz-Cruz, EJ; Ozger, H; Ozkan, K; Pala, E; Palmerini, E; Pang, G; Papagelopoulos, P; Paraliticci, G; Parry, MC; Patton, S; Peake, D; Peiro, Ibanez, A; Perez, Munoz, I; Perianayagam, GR; Petersen, MM; Ploegmakers, J; Pollock, R; Powell, G; Pretell, J; Puetzler, J; Qamar, F; Raja, A; Rajasekaran, RB; ... A modified Delphi consensus on periprosthetic infection in orthopaedic oncology : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).
Bone Joint J. 2025; 107-B(12): 1352-1359. Doi: 10.1302/0301-620X.107B12.BJJ-2024-1039.R4
PubMed FullText FullText_MUG

 

01.12.2025:

Bischof, H; Cisarova, K; Burgstaller, S; Schwerer, M; Absenger-Novak, M; Jost, PJ; Malli, R; Graier, WF; Lukowski, R Targeting hexokinase 2 to induce breast cancer cell senescence.
Br J Pharmacol. 2025; Doi: 10.1111/bph.70282
PubMed FullText FullText_MUG

 

27.11.2025:

Damulina, A; Opriessnig, P; Pirpamer, L; Demjaha, R; Tafrali, C; Martinez-Serrat, M; Hofer, E; Wurth, S; Heschl, B; Hochmeister, S; Archelos, JJ; Pinter, D; Ropele, S; Enzinger, C; Khalil, M Association of CSF Kappa-Free Light Chains With Cortical and Periventricular Brain Damage in Multiple Sclerosis.
Neurology. 2025; 105(12): e214433 Doi: 10.1212/WNL.0000000000214433 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

26.11.2025:

Shelmerdine, SC; Naidoo, J; Kelly, BS; Laborie, LB; Toso, S; D'Antonoli, TA; Arthurs, OJ; Blumer, SL; Ciet, P; Damasio, MB; Doria, AS; Haque, S; Ho, ML; Huisman, TAGM; Joshi, A; Kapur, J; Mankad, K; Offiah, AC; Otero, HJ; Pace, E; Semple, T; Sodhi, KS; Tschauner, S; Ugas-Charcape, CF; Vamyanmane, DK; van, Rijn, RR; Veiga-Canuto, D; Wagner, MW; Zucker, EJ; Sammer, M Artificial Intelligence Implementation in Pediatric Radiology for Patient Safety: A Multisociety Statement From the ACR, ESPR, SPR, SLARP, AOSPR, SPIN.
J Am Coll Radiol. 2025; Doi: 10.1016/j.jacr.2025.08.019
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)

Med Uni Graz publications¹ were assigned quintiles according to the normalized² Clarivate’s Journal Impact Factor of the journal at the time of publication.

Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).

Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.

¹ This analysis considered only publications categorized as full papers/original articles.

² IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.